{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:40:20Z","timestamp":1791510020931,"version":"4.3.4"},"reference-count":233,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01974","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T04:54:16Z","timestamp":1566276856000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":83,"title":["Serological Diagnosis of Autoimmune Bullous Skin Diseases"],"prefix":"10.3389","volume":"10","author":[{"given":"Sandra","family":"Saschenbrecker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingolf","family":"Karl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Komorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Probst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"D\u00e4hnrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Fechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"St\u00f6cker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Schlumberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,20]]},"reference":[{"key":"B1","first-page":"28","article-title":"Multiplex serological diagnostics in autoimmune skin-blistering diseases","volume":"4","author":"Gosink","year":"2016","journal-title":"MEDLAB Magazine"},{"key":"B2","doi-asserted-by":"publisher","first-page":"17026","DOI":"10.1038\/nrdp.2017.27","article-title":"Pemphigus","volume":"3","author":"Kasperkiewicz","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet Lond Engl"},{"key":"B4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jid.2017.06.022","article-title":"Mechanisms causing loss of keratinocyte cohesion in pemphigus","volume":"138","author":"Spindler","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00281-015-0541-1","article-title":"Immune response in pemphigus and beyond: progresses and emerging concepts","volume":"38","author":"Di Zenzo","year":"2016","journal-title":"Semin Immunopathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/1523-1747.ep12343081","article-title":"Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients","volume":"106","author":"Amagai","year":"1996","journal-title":"J Invest Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2302\/kjm.51.133","article-title":"Pemphigus as a paradigm of autoimmunity and cell adhesion","volume":"51","author":"Amagai","year":"2002","journal-title":"Keio J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1046\/j.1523-1747.1998.00085.x","article-title":"Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1","volume":"110","author":"Shirakata","year":"1998","journal-title":"J Invest Dermatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0190-9622(99)70183-0","article-title":"The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile","volume":"40","author":"Amagai","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/1523-1747.ep12337524","article-title":"Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles","volume":"109","author":"Ding","year":"1997","journal-title":"J Invest Dermatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1172\/JCI5252","article-title":"Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris","volume":"103","author":"Mahoney","year":"1999","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e57587","DOI":"10.1371\/journal.pone.0057587","article-title":"Pemphigus vulgaris autoantibody profiling by proteomic technique","volume":"8","author":"Kalantari-Dehaghi","year":"2013","journal-title":"PLoS ONE"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3389\/fimmu.2018.01190","article-title":"Non-desmoglein antibodies in patients with pemphigus vulgaris","volume":"9","author":"Amber","year":"2018","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/exd.13106","article-title":"Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology","volume":"25","author":"Ahmed","year":"2016","journal-title":"Exp Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jaad.2016.11.039","article-title":"Correlation of antimuscarinic acetylcholine receptor antibody titers and antidesmoglein antibody titers with the severity of disease in patients with pemphigus","volume":"76","author":"Lakshmi","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.clindermatol.2011.01.014","article-title":"IgA pemphigus","volume":"29","author":"Tsuruta","year":"2011","journal-title":"Clin Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/bjd.15034","article-title":"Intercellular IgA dermatosis","volume":"176","author":"Tsuruta","year":"2017","journal-title":"Br J Dermatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2133.2004.05995.x","article-title":"The detection of IgG and IgA autoantibodies to desmocollins 1\u20133 by enzyme-linked immunosorbent assays using baculovirus-expressed proteins, in atypical pemphigus but not in typical pemphigus","volume":"151","author":"Hisamatsu","year":"2004","journal-title":"Br J Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/1523-1747.ep12319025","article-title":"Human desmocollin 1 (Dsc1) is an autoantigen for the subcorneal pustular dermatosis type of IgA pemphigus","volume":"109","author":"Hashimoto","year":"1997","journal-title":"J Invest Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/j.1365-2230.2009.03241.x","article-title":"Autoantibodies against desmocollins in European patients with pemphigus","volume":"34","author":"Muller","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jdermsci.2016.04.001","article-title":"Establishment of IgA ELISAs of mammalian recombinant proteins of human desmocollins 1\u20133","volume":"83","author":"Teye","year":"2016","journal-title":"J Dermatol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1087-0024.2004.00832.x","article-title":"Paraneoplastic pemphigus","volume":"9","author":"Anhalt","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3389\/fimmu.2019.01259","article-title":"Paraneoplastic pemphigus: paraneoplastic autoimmune disease of the skin and mucosa","volume":"10","author":"Kim","year":"2019","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/bjd.14162","article-title":"Clinical and immunological findings in 104 cases of paraneoplastic pemphigus","volume":"173","author":"Ohzono","year":"2015","journal-title":"Br J Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e12250","DOI":"10.1371\/journal.pone.0012250","article-title":"The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human","volume":"5","author":"Schepens","year":"2010","journal-title":"PLoS ONE"},{"key":"B26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2147\/CCID.S100802","article-title":"Paraneoplastic pemphigus: a short review","volume":"9","author":"Wieczorek","year":"2016","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/ced.12296","article-title":"Paraneoplastic pemphigus with eosinophilic spongiosis and autoantibodies against desmocollins 2 and 3","volume":"39","author":"Gallo","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1172\/JCI115781","article-title":"Human autoantibodies against desmoplakins in paraneoplastic pemphigus","volume":"89","author":"Oursler","year":"1992","journal-title":"J Clin Invest"},{"key":"B29","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1172\/JCI3647","article-title":"Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice","volume":"102","author":"Amagai","year":"1998","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1046\/j.1523-1747.1998.00449.x","article-title":"Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex","volume":"111","author":"Kiyokawa","year":"1998","journal-title":"J Invest Dermatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1046\/j.1523-1747.1999.00695.x","article-title":"Plectin serves as an autoantigen in paraneoplastic pemphigus","volume":"113","author":"Aho","year":"1999","journal-title":"J Invest Dermatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1038\/jid.2012.1","article-title":"Differential IgG recognition of desmoglein 3 by paraneoplastic pemphigus and pemphigus vulgaris sera","volume":"132","author":"Brandt","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/bjd.13711","article-title":"Anti-desmocollin autoantibodies in nonclassical pemphigus","volume":"173","author":"Ishii","year":"2015","journal-title":"Br J Dermatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/j.1610-0387.2010.07380.x","article-title":"Clinical and immunopathological spectrum of paraneoplastic pemphigus","volume":"8","author":"Zimmermann","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"B35","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1067\/mjd.2000.107488","article-title":"Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus","volume":"43","author":"Joly","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cca.2009.08.022","article-title":"Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus","volume":"410","author":"Probst","year":"2009","journal-title":"Clin Chim Acta"},{"key":"B37","first-page":"1103","article-title":"Evaluation of a newly available ELISA for envoplakin autoantibodies for the diagnosis of paraneoplastic pemphigus","volume":"14","author":"Powell","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/bjd.12479","article-title":"Laboratory diagnosis of paraneoplastic pemphigus","volume":"169","author":"Poot","year":"2013","journal-title":"Br J Dermatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000468919","article-title":"Atypical clinical and serological manifestation of pemphigus vegetans: a case report and review of the literature","volume":"9","author":"Mergler","year":"2017","journal-title":"Case Rep Dermatol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"296214","DOI":"10.1155\/2012\/296214","article-title":"Autoantibodies in senear-usher syndrome: cross-reactivity or multiple autoimmunity?","volume":"2012","author":"Perez-Perez","year":"2012","journal-title":"Autoimmune Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1365-4362.1985.tb05349.x","article-title":"Pemphigus erythematosus. Senear-Usher syndrome","volume":"24","author":"Amerian","year":"1985","journal-title":"Int J Dermatol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jaad.2013.11.043","article-title":"Pemphigus herpetiformis: from first description until now","volume":"70","author":"Kasperkiewicz","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/1346-8138.12675","article-title":"Update on fogo selvagem, an endemic form of pemphigus foliaceus","volume":"42","author":"Aoki","year":"2015","journal-title":"J Dermatol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0738-081X(98)00010-8","article-title":"Drug-induced pemphigus","volume":"16","author":"Brenner","year":"1998","journal-title":"Clin Dermatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/bjd.12925","article-title":"Clinical and immunological profiles in 17 Japanese patients with drug-induced pemphigus studied at Kurume University","volume":"171","author":"Yoshimura","year":"2014","journal-title":"Br J Dermatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/exd.13446","article-title":"Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases","volume":"26","author":"Goletz","year":"2017","journal-title":"Exp Dermatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fmed.2018.00220","article-title":"The growing incidence of bullous pemphigoid: overview and potential explanations","volume":"5","author":"Kridin","year":"2018","journal-title":"Front Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/1523-1747.ep12337492","article-title":"Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies","volume":"109","author":"Zillikens","year":"1997","journal-title":"J Invest Dermatol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1046\/j.1523-1747.2000.00893.x","article-title":"IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230","volume":"114","author":"Skaria","year":"2000","journal-title":"J Invest Dermatol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jdermsci.2005.11.002","article-title":"Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid","volume":"41","author":"Yoshida","year":"2006","journal-title":"J Dermatol Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1001\/archdermatol.2011.23","article-title":"Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients","volume":"147","author":"Charneux","year":"2011","journal-title":"Arch Dermatol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.clim.2008.04.012","article-title":"Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid","volume":"128","author":"Di Zenzo","year":"2008","journal-title":"Clin Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/archdermatol.2011.21","article-title":"Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid","volume":"147","author":"Roussel","year":"2011","journal-title":"Arch Dermatol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/j.1365-2133.2012.10820.x","article-title":"Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid","volume":"166","author":"Blocker","year":"2012","journal-title":"Br J Dermatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.0022-202X.2003.22126.x","article-title":"Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients","volume":"122","author":"Di Zenzo","year":"2004","journal-title":"J Invest Dermatol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/01.AOG.0000115506.76104.ad","article-title":"Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis","volume":"103","author":"Sitaru","year":"2004","journal-title":"Obstet Gynecol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/sj.jid.5700594","article-title":"The intracellular and extracellular domains of BP180 antigen comprise novel epitopes targeted by pemphigoid gestationis autoantibodies","volume":"127","author":"Di Zenzo","year":"2007","journal-title":"J Invest Dermatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1172\/JCI114508","article-title":"Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis","volume":"85","author":"Zone","year":"1990","journal-title":"J Clin Invest"},{"key":"B59","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/1523-1747.ep12345782","article-title":"LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells","volume":"106","author":"Marinkovich","year":"1996","journal-title":"J Invest Dermatol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.clindermatol.2011.03.008","article-title":"Linear immunoglobulin A bullous dermatosis","volume":"30","author":"Fortuna","year":"2012","journal-title":"Clin Dermatol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1046\/j.1523-1747.2003.12607.x","article-title":"The 97-kDa (LABD97) and 120-kDa (LAD-1) fragments of bullous pemphigoid antigen 180\/type XVII collagen have different N-termini","volume":"121","author":"Hirako","year":"2003","journal-title":"J Invest Dermatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1046\/j.1523-1747.1999.00808.x","article-title":"Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801","volume":"113","author":"Zillikens","year":"1999","journal-title":"J Invest Dermatol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1046\/j.1365-2133.1999.02618.x","article-title":"Childhood bullous pemphigoid associated with IgA antibodies against BP180 or BP230 antigens","volume":"140","author":"Arechalde","year":"1999","journal-title":"Br J Dermatol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/1523-1747.ep12292581","article-title":"Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens","volume":"108","author":"Ghohestani","year":"1997","journal-title":"J Invest Dermatol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fimmu.2019.00034","article-title":"The diagnosis and blistering mechanisms of mucous membrane pemphigoid","volume":"10","author":"Kamaguchi","year":"2019","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/1523-1747.ep12329728","article-title":"Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain","volume":"106","author":"Balding","year":"1996","journal-title":"J Invest Dermatol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/1523-1747.ep12292701","article-title":"Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida","volume":"108","author":"Bedane","year":"1997","journal-title":"J Invest Dermatol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1365-2133.2005.06998.x","article-title":"Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity","volume":"154","author":"Oyama","year":"2006","journal-title":"Br J Dermatol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1046\/j.1365-2133.2001.04471.x","article-title":"Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180","volume":"145","author":"Schmidt","year":"2001","journal-title":"Br J Dermatol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jaad.2008.02.035","article-title":"IgG anti-laminin-332 autoantibodies are present in a subset of patients with mucous membrane, but not bullous, pemphigoid","volume":"58","author":"Lazarova","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.0022-202X.2005.23646.x","article-title":"Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA","volume":"124","author":"Bekou","year":"2005","journal-title":"J Invest Dermatol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/bjd.17202","article-title":"A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid","volume":"180","author":"Goletz","year":"2019","journal-title":"Br J Dermatol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/S0140-6736(00)04971-0","article-title":"Anti-epiligrin cicatricial pemphigoid and relative risk for cancer","volume":"357","author":"Egan","year":"2001","journal-title":"Lancet"},{"key":"B74","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/1523-1747.ep12876206","article-title":"Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis","volume":"94","author":"Bernard","year":"1990","journal-title":"J Invest Dermatol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1046\/j.1365-2133.2001.04543.x","article-title":"Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230","volume":"145","author":"Leverkus","year":"2001","journal-title":"Br J Dermatol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.4049\/jimmunol.165.5.2824","article-title":"The autoantibodies to alpha 6 beta 4 integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large cytoplasmic domain of human beta 4","volume":"165","author":"Bhol","year":"2000","journal-title":"J Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1684\/ejd.2016.2772","article-title":"Integrin beta4 is a major target antigen in pure ocular mucous membrane pemphigoid","volume":"26","author":"Li","year":"2016","journal-title":"Eur J Dermatol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12016-017-8633-4","article-title":"Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management","volume":"54","author":"Amber","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1346-8138.2007.00208.x","article-title":"Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease","volume":"34","author":"Dilling","year":"2007","journal-title":"J Dermatol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/1523-1747.ep12349283","article-title":"A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone","volume":"106","author":"Zillikens","year":"1996","journal-title":"J Invest Dermatol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1346-8138.2009.00793.x","article-title":"From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid","volume":"37","author":"Dainichi","year":"2010","journal-title":"J Dermatol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3389\/fimmu.2019.01389","article-title":"Lichen planus pemphigoides: from lichenoid inflammation to autoantibody-mediated blistering","volume":"10","author":"Hubner","year":"2019","journal-title":"Front Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/0190-9622(95)91554-0","article-title":"Lichen planus pemphigoides: identification of 180 kd hemidesmosome antigen","volume":"32","author":"Tamada","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1046\/j.1523-1747.1999.00618.x","article-title":"Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180","volume":"113","author":"Zillikens","year":"1999","journal-title":"J Invest Dermatol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.4081\/dr.2011.e38","article-title":"Epidermolysis bullosa acquisita: current diagnosis and therapy","volume":"3","author":"Mehren","year":"2011","journal-title":"Dermatol Rep"},{"key":"B86","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fmed.2018.00362","article-title":"Epidermolysis bullosa acquisita: the 2019 update","volume":"5","author":"Koga","year":"2018","journal-title":"Front Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1346-8138.2009.00799.x","article-title":"Epidermolysis bullosa acquisita: what's new?","volume":"37","author":"Ishii","year":"2010","journal-title":"J Dermatol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJM198404193101602","article-title":"Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita","volume":"310","author":"Woodley","year":"1984","journal-title":"N Engl J Med"},{"key":"B89","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/1523-1747.ep12612780","article-title":"Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the noncollagenous (NC1) domain","volume":"104","author":"Jones","year":"1995","journal-title":"J Invest Dermatol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1172\/JCI116774","article-title":"Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa","volume":"92","author":"Lapiere","year":"1993","journal-title":"J Clin Invest"},{"key":"B91","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2133.1984.tb06601.x","article-title":"IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease","volume":"111","author":"Chorzelski","year":"1984","journal-title":"Br J Dermatol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jaad.2011.02.025","article-title":"Novel assay for detecting celiac disease-associated autoantibodies in dermatitis herpetiformis using deamidated gliadin-analogous fusion peptides","volume":"66","author":"Kasperkiewicz","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nm0797-797","article-title":"Identification of tissue transglutaminase as the autoantigen of celiac disease","volume":"3","author":"Dieterich","year":"1997","journal-title":"Nat Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaad.2008.12.037","article-title":"Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet","volume":"61","author":"Rose","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1084\/jem.20011299","article-title":"Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis","volume":"195","author":"Sardy","year":"2002","journal-title":"J Exp Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1373\/clinchem.2009.128132","article-title":"IgG antibodies against deamidated gliadin peptides for diagnosis of celiac disease in patients with IgA deficiency","volume":"56","author":"Villalta","year":"2010","journal-title":"Clin Chem"},{"key":"B97","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/ddg.12612","article-title":"S2k guideline for the diagnosis of pemphigus vulgaris\/foliaceus and bullous pemphigoid","volume":"13","author":"Schmidt","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"key":"B98","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/j.1610-0387.2011.07809.x","article-title":"Autoimmune bullous skin diseases. Part 2: diagnosis and therapy","volume":"9","author":"Kneisel","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"B99","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.autrev.2010.08.007","article-title":"Modern diagnosis of autoimmune blistering skin diseases","volume":"10","author":"Schmidt","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/ddg.13637","article-title":"Diagnosis of autoimmune bullous diseases","volume":"16","author":"van Beek","year":"2018","journal-title":"J Dtsch Dermatol Ges"},{"key":"B101","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/bjd.16138","article-title":"International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita","volume":"179","author":"Prost-Squarcioni","year":"2018","journal-title":"Br J Dermatol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.02.021","article-title":"Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts","author":"Murrell","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fmed.2018.00296","article-title":"Diagnosis of Autoimmune Blistering Diseases","volume":"5","author":"Witte","year":"2018","journal-title":"Front Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/bjd.14692","article-title":"Summary of results of serological tests and diagnoses for 4774 cases of various autoimmune bullous diseases consulted to Kurume University","volume":"175","author":"Hashimoto","year":"2016","journal-title":"Br J Dermatol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/j.1610-0387.2011.07793.x","article-title":"Autoimmune bullous skin diseases. Part 1: clinical manifestations","volume":"9","author":"Kneisel","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"B106","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jaad.2013.07.009","article-title":"Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid","volume":"69","author":"Sardy","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B107","first-page":"730","article-title":"Direct immunofluorescence in cutaneous vesiculobullous lesions","volume":"50","author":"Inchara","year":"2007","journal-title":"Indian J Pathol Microbiol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1046\/j.1365-2230.2003.01419.x","article-title":"Comparison of immunofluorescence microscopy, immunoblotting and enzyme-linked immunosorbent assay methods in the laboratory diagnosis of bullous pemphigoid","volume":"28","author":"Chan","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/bjd.14408","article-title":"Laboratory diagnosis of pemphigus: direct immunofluorescence remains the gold standard","volume":"175","author":"Giurdanella","year":"2016","journal-title":"Br J Dermatol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fmed.2018.00020","article-title":"Direct immunofluorescence using non-lesional buccal mucosa in mucous membrane pemphigoid","volume":"5","author":"Kamaguchi","year":"2018","journal-title":"Front Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jaad.2017.11.029","article-title":"Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseases","volume":"78","author":"Meijer","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3238\/arztebl.2011.0399","article-title":"The diagnosis and treatment of autoimmune blistering skin diseases","volume":"108","author":"Schmidt","year":"2011","journal-title":"Dtsch Arztebl Int"},{"key":"B113","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1750-1172-7-49","article-title":"Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy","volume":"7","author":"van Beek","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"B114","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jaad.2016.11.002","article-title":"Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases","volume":"76","author":"van Beek","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3389\/fimmu.2018.00839","article-title":"Keratinocyte binding assay identifies anti-desmosomal pemphigus antibodies where other tests are negative","volume":"9","author":"Giurdanella","year":"2018","journal-title":"Front Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/bjd.15930","article-title":"British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017","volume":"177","author":"Harman","year":"2017","journal-title":"Br J Dermatol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.clindermatol.2011.03.014","article-title":"Current therapy of the pemphigus group","volume":"30","author":"Kasperkiewicz","year":"2012","journal-title":"Clin Dermatol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jaad.2010.04.039","article-title":"A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus","volume":"64","author":"Martin","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/jid.2008.412","article-title":"A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study","volume":"129","author":"Joly","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/j.1365-2133.2011.10732.x","article-title":"Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris","volume":"166","author":"Behzad","year":"2012","journal-title":"Br J Dermatol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/08916930600972040","article-title":"Immunoadsorption in pemphigus","volume":"39","author":"Eming","year":"2006","journal-title":"Autoimmunity"},{"key":"B122","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/j.1365-2133.2005.06651.x","article-title":"Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus","volume":"153","author":"Arin","year":"2005","journal-title":"Br J Dermatol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1610-0387.2007.06602.x","article-title":"Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases","volume":"6","author":"Hertl","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"B124","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1172\/JCI117349","article-title":"Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus","volume":"94","author":"Amagai","year":"1994","journal-title":"J Clin Invest"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323","author":"Anhalt","year":"1990","journal-title":"N Engl J Med"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1046\/j.1365-2133.2000.03538.x","article-title":"The use of two substrates to improve the sensitivity of indirect immunofluorescence in the diagnosis of pemphigus","volume":"142","author":"Harman","year":"2000","journal-title":"Br J Dermatol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0190-9622(97)80127-2","article-title":"Sensitivity of indirect immunofluorescence, substrate specificity, and immunoblotting in the diagnosis of pemphigus","volume":"37","author":"Jiao","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s001050051193","article-title":"[Clinical aspects and immunopathology in 48 patients with pemphigus]","volume":"51","author":"Hahn","year":"2000","journal-title":"Hautarzt"},{"key":"B129","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1365-4632.2004.02541.x","article-title":"A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris","volume":"44","author":"Zagorodniuk","year":"2005","journal-title":"Int J Dermatol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1440-0960.2005.00191.x","article-title":"Comparison of desmoglein ELISA and indirect immunofluorescence using two substrates (monkey oesophagus and normal human skin) in the diagnosis of pemphigus","volume":"46","author":"Ng","year":"2005","journal-title":"Australas J Dermatol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/1523-1747.ep12470131","article-title":"Substrate specificity of anti-epithelial antibodies of pemphigus vulgaris and pemphigus foliaceus sera in immunofluorescence tests on monkey and guinea pig esophagus sections","volume":"88","author":"Sabolinski","year":"1987","journal-title":"J Invest Dermatol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fmed.2018.00266","article-title":"The usefulness of indirect immunofluorescence in pemphigus and the natural history of patients with initial false-positive results: a Retrospective Cohort Study","volume":"5","author":"Kridin","year":"2018","journal-title":"Front Med"},{"key":"B133","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s001050051001","article-title":"[Immunopathologic changes in 115 patients with bullous pemphigoid]","volume":"50","author":"Kippes","year":"1999","journal-title":"Hautarzt"},{"key":"B134","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3109\/00313025.2010.508792","article-title":"False-positive intercellular cement substance antibodies due to group A\/B red cell antibodies: frequency and approach","volume":"42","author":"Lee","year":"2010","journal-title":"Pathology"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1001\/archderm.133.9.1102","article-title":"Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses","volume":"133","author":"Ghohestani","year":"1997","journal-title":"Arch Dermatol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0190-9622(92)70161-8","article-title":"Immunofluorescence on split skin for the detection and differentiation of basement membrane zone autoantibodies","volume":"27","author":"Gammon","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1365-2133.1996.tb03611.x","article-title":"Comparative sensitivity of indirect immunofluorescence to immunoblot assay for the detection of circulating antibodies to bullous pemphigoid antigens 1 and 2","volume":"135","author":"Ghohestani","year":"1996","journal-title":"Br J Dermatol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.03.077","article-title":"Anti-p200 pemphigoid is the most common pemphigoid disease with serum antibodies against the dermal side by indirect immunofluorescence microscopy on human salt-split skin","author":"Lau","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0190-9622(93)70095-B","article-title":"Indirect immunofluorescence on rat bladder transitional epithelium: a test with high specificity for paraneoplastic pemphigus","volume":"28","author":"Liu","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/BF00516548","article-title":"Circulating IgA- and IgG-class antigliadin antibodies in dermatitis herpetiformis detected by enzyme-linked immunosorbent assay","volume":"275","author":"Vainio","year":"1983","journal-title":"Arch Dermatol Res"},{"key":"B141","first-page":"179","article-title":"Novel recombinant antigenic targets for the determination of (auto)antibodies in autoimmune dermatoses, neurological disorders and gastrointestinal diseases","volume-title":"From Pathogenesis to Therapy of Autoimmune Diseases.","author":"Wandinger","year":"2009"},{"key":"B142","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1373\/clinchem.2004.036111","article-title":"Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease","volume":"50","author":"Schwertz","year":"2004","journal-title":"Clin Chem"},{"key":"B143","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1600-0625.2007.00592.x","article-title":"Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies","volume":"16","author":"Sitaru","year":"2007","journal-title":"Exp Dermatol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jim.2012.05.007","article-title":"Autoantibody detection in bullous pemphigoid: clinical evaluation of the EUROPLUS Dermatology Mosaic","volume":"382","author":"Damoiseaux","year":"2012","journal-title":"J Immunol Methods"},{"key":"B145","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/MPG.0b013e318195dae3","article-title":"Antibodies against deamidated gliadin as new and accurate biomarkers of childhood coeliac disease","volume":"49","author":"Prause","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B146","first-page":"269","article-title":"[Rational histochemistry using a new microanalytic technic]","volume":"31","author":"St\u00f6cker","year":"1985","journal-title":"Acta Histochem Suppl"},{"key":"B147","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1600-0625.2010.01069.x","article-title":"Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients","volume":"19","author":"Schmidt","year":"2010","journal-title":"Exp Dermatol"},{"key":"B148","first-page":"16","article-title":"Autoantibody diagnostics in skin-blistering diseases","volume":"4","author":"Gosink","year":"2013","journal-title":"MEDLAB Magazine"},{"key":"B149","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/j.jaad.2011.12.032","article-title":"Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita","volume":"68","author":"Komorowski","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijwd.2017.10.001","article-title":"New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: a review of the literature","volume":"4","author":"Xuan","year":"2018","journal-title":"Int J Womens Dermatol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1111\/ajd.13034","article-title":"A new indirect immunofluorescence BIOCHIP method for the serological diagnosis of bullous pemphigoid: a review of literature","volume":"60","author":"Yang","year":"2019","journal-title":"Australas J Dermatol"},{"key":"B152","first-page":"202","article-title":"The value of the BIOCHIP mosaic-based indirect immunofluorescence technique in the diagnosis of pemphigus and bullous pemphigoid in Turkish patients","volume":"25","author":"\u00d6zkesici","year":"2017","journal-title":"Acta Dermatovenerol Croat"},{"key":"B153","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.acthis.2013.12.012","article-title":"The use of biochip immunofluorescence microscopy for the diagnosis of Pemphigus vulgaris","volume":"116","author":"Russo","year":"2014","journal-title":"Acta Histochem"},{"key":"B154","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000339776","article-title":"Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases","volume":"225","author":"Tampoia","year":"2012","journal-title":"Dermatology"},{"key":"B155","doi-asserted-by":"publisher","first-page":"237802","DOI":"10.5402\/2012\/237802","article-title":"Biochip technology for the serological diagnosis of bullous pemphigoid","volume":"2012","author":"Zarian","year":"2012","journal-title":"ISRN Dermatol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.det.2011.06.007","article-title":"Diagnosis and treatment of patients with autoimmune bullous disorders in Germany","volume":"29","author":"Schmidt","year":"2011","journal-title":"Dermatol Clin"},{"key":"B157","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2340\/00015555-2460","article-title":"Value of BIOCHIP technology in the serological diagnosis of pemphigoid gestationis","volume":"97","author":"Sadik","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/exd.13409","article-title":"Routine detection of serum antidesmocollin autoantibodies is only useful in patients with atypical pemphigus","volume":"26","author":"Mindorf","year":"2017","journal-title":"Exp Dermatol"},{"key":"B159","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.159.4.2010","article-title":"Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins","volume":"159","author":"Ishii","year":"1997","journal-title":"J Immunol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0923-1811(02)00109-3","article-title":"BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid","volume":"30","author":"Kobayashi","year":"2002","journal-title":"J Dermatol Sci"},{"key":"B161","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/bjd.12011","article-title":"Diagnosis and disease severity assessment of epidermolysis bullosa acquisita by ELISA for anti-type VII collagen autoantibodies: an Italian multicentre study","volume":"168","author":"Marzano","year":"2013","journal-title":"Br J Dermatol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2133.2010.10056.x","article-title":"Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid","volume":"164","author":"Groth","year":"2011","journal-title":"Br J Dermatol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1001\/jamadermatol.2013.1434","article-title":"Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid","volume":"149","author":"Bernard","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1046\/j.1523-1747.2002.19529.x","article-title":"Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain","volume":"119","author":"Hofmann","year":"2002","journal-title":"J Invest Dermatol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1684\/ejd.2015.2692","article-title":"Diagnostic performance of the \u201cMESACUP anti-Skin profile TEST\u201d","volume":"26","author":"Horvath","year":"2016","journal-title":"Eur J Dermatol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1046\/j.1365-2133.1999.02752.x","article-title":"Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus","volume":"140","author":"Amagai","year":"1999","journal-title":"Br J Dermatol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1046\/j.1365-2230.2000.00624.x","article-title":"Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3","volume":"25","author":"Harman","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1726-4901(09)70304-1","article-title":"Using desmoglein 1 and 3 enzyme-linked immunosorbent assay as an adjunct diagnostic tool for pemphigus","volume":"70","author":"Huang","year":"2007","journal-title":"J Chin Med Assoc."},{"key":"B169","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1128\/CDLI.11.4.762-765.2004","article-title":"Evaluation of recombinant antigen-based assays for diagnosis of bullous autoimmune diseases","volume":"11","author":"D'Agosto","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1468-3083.2007.02254.x","article-title":"Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity","volume":"21","author":"Daneshpazhooh","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1468-3083.2009.03408.x","article-title":"Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity","volume":"24","author":"Hallaji","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1365-4632.2006.02593.x","article-title":"Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris","volume":"45","author":"Sharma","year":"2006","journal-title":"Int J Dermatol"},{"key":"B173","first-page":"1","article-title":"Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari","volume":"143","author":"Atzori","year":"2008","journal-title":"G Ital Dermatol Venereol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/1523-1747.ep12338088","article-title":"A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid","volume":"109","author":"Zillikens","year":"1997","journal-title":"J Invest Dermatol"},{"key":"B175","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00403-016-1631-1","article-title":"Evaluation of ELISA testing for BP180 and BP230 as a diagnostic modality for bullous pemphigoid: a clinical experience","volume":"308","author":"Keller","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"B176","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1749-6632.2009.04630.x","article-title":"Evaluation of a new ELISA assay for detection of BP230 autoantibodies in bullous pemphigoid","volume":"1173","author":"Tampoia","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"B177","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1111\/j.0022-202X.2004.22603.x","article-title":"BP230- and BP180-specific auto-antibodies in bullous pemphigoid","volume":"122","author":"Thoma-Uszynski","year":"2004","journal-title":"J Invest Dermatol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1365-2133.2004.06082.x","article-title":"Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid","volume":"151","author":"Sakuma-Oyama","year":"2004","journal-title":"Br J Dermatol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/j.1365-2133.2004.06245.x","article-title":"Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients","volume":"151","author":"Mariotti","year":"2004","journal-title":"Br J Dermatol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/j.1365-4632.2008.03824.x","article-title":"Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis","volume":"47","author":"Barnadas","year":"2008","journal-title":"Int J Dermatol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jim.2009.04.013","article-title":"A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid","volume":"346","author":"Messingham","year":"2009","journal-title":"J Immunol Methods"},{"key":"B182","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.clim.2003.12.007","article-title":"Development of an ELISA for the detection of autoantibodies to BP230","volume":"111","author":"Kromminga","year":"2004","journal-title":"Clin Immunol"},{"key":"B183","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1111\/bjd.15800","article-title":"Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis","volume":"177","author":"Schmidt","year":"2017","journal-title":"Br J Dermatol"},{"key":"B184","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jdermsci.2011.03.003","article-title":"Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients","volume":"62","author":"Saleh","year":"2011","journal-title":"J Dermatol Sci"},{"key":"B185","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.1111\/j.1468-3083.2012.04617.x","article-title":"Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions","volume":"27","author":"Kim","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B186","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/1523-1747.ep12285634","article-title":"Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita","volume":"108","author":"Chen","year":"1997","journal-title":"J Invest Dermatol"},{"key":"B187","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1093\/clinchem\/45.12.2142","article-title":"Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy","volume":"45","author":"Sardy","year":"1999","journal-title":"Clin Chem"},{"key":"B188","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1055\/s-2000-14883","article-title":"Comparison of a tissue transglutaminase ELISA with the endomysium antibody test in the diagnosis of gluten-sensitive enteropathy","volume":"38","author":"Sardy","year":"2000","journal-title":"Z Gastroenterol"},{"key":"B189","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.patbio.2004.07.022","article-title":"Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay","volume":"53","author":"Mankai","year":"2005","journal-title":"Pathol Biol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.autrev.2012.07.006","article-title":"Diagnostic accuracy of enzyme-linked immunosorbent assays (ELISA) to detect anti-skin autoantibodies in autoimmune blistering skin diseases: a systematic review and meta-analysis","volume":"12","author":"Tampoia","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B191","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0923-1811(03)00158-0","article-title":"Usefulness of immunoblotting using purified laminin 5 in the diagnosis of anti-laminin 5 cicatricial pemphigoid","volume":"33","author":"Hisamatsu","year":"2003","journal-title":"J Dermatol Sci"},{"key":"B192","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1365-2249.2006.03103.x","article-title":"Comparison of reactivity and epitope recognition between sera from American and Italian patients with oral pemphigoid","volume":"145","author":"Mignogna","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1365-2133.2004.05933.x","article-title":"Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy","volume":"150","author":"Ishii","year":"2004","journal-title":"Br J Dermatol"},{"key":"B194","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1046\/j.1523-1747.2000.00137.x","article-title":"Use of domain-swapped molecules for conformational epitope mapping of desmoglein 3 in pemphigus vulgaris","volume":"115","author":"Futei","year":"2000","journal-title":"J Invest Dermatol"},{"key":"B195","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/1523-1747.ep12317587","article-title":"Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent","volume":"105","author":"Amagai","year":"1995","journal-title":"J Invest Dermatol"},{"key":"B196","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/1523-1747.ep12316680","article-title":"Pemphigus sera recognize conformationally sensitive epitopes in the amino-terminal region of desmoglein-1","volume":"105","author":"Kowalczyk","year":"1995","journal-title":"J Invest Dermatol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1600-0625.2009.00948.x","article-title":"Animal models for autoimmune bullous dermatoses","volume":"19","author":"Bieber","year":"2010","journal-title":"Exp Dermatol"},{"key":"B198","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jaut.2008.08.003","article-title":"Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity","volume":"31","author":"Culton","year":"2008","journal-title":"J Autoimmun"},{"key":"B199","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jaut.2008.08.009","article-title":"Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model","volume":"31","author":"Liu","year":"2008","journal-title":"J Autoimmun"},{"key":"B200","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/1523-1747.ep12513454","article-title":"Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum","volume":"67","author":"Schiltz","year":"1976","journal-title":"J Invest Dermatol"},{"key":"B201","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1056\/NEJM198205203062001","article-title":"Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease","volume":"306","author":"Anhalt","year":"1982","journal-title":"N Engl J Med"},{"key":"B202","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1046\/j.1523-1747.2000.00829.x","article-title":"Human anti-laminin 5 autoantibodies induce subepidermal blisters in an experimental human skin graft model","volume":"114","author":"Lazarova","year":"2000","journal-title":"J Invest Dermatol"},{"key":"B203","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/j.0022-202X.2005.23702.x","article-title":"Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita","volume":"124","author":"Woodley","year":"2005","journal-title":"J Invest Dermatol"},{"key":"B204","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/fimmu.2017.00603","article-title":"Mechanisms of autoantibody-induced pathology","volume":"8","author":"Ludwig","year":"2017","journal-title":"Front Immunol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3389\/fimmu.2019.01506","article-title":"New insights into the pathogenesis of bullous pemphigoid: 2019 update","volume":"10","author":"Genovese","year":"2019","journal-title":"Front Immunol"},{"key":"B206","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000187431","article-title":"Clinical and immunological follow-up of pemphigus patients on adjuvant treatment with immunoadsorption or rituximab","volume":"218","author":"Pfutze","year":"2009","journal-title":"Dermatology"},{"key":"B207","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1046\/j.1365-2133.2002.04838.x","article-title":"Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3","volume":"147","author":"Cheng","year":"2002","journal-title":"Br J Dermatol"},{"key":"B208","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1046\/j.1365-2133.2001.04132.x","article-title":"The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels","volume":"144","author":"Harman","year":"2001","journal-title":"Br J Dermatol"},{"key":"B209","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/archdermatol.2009.9","article-title":"ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus","volume":"145","author":"Abasq","year":"2009","journal-title":"Arch Dermatol"},{"key":"B210","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch Dermatol"},{"key":"B211","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jdermsci.2004.10.007","article-title":"Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid","volume":"37","author":"Tsuji-Abe","year":"2005","journal-title":"J Dermatol Sci"},{"key":"B212","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1365-4632.2008.03473.x","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"47","author":"Feng","year":"2008","journal-title":"Int J Dermatol"},{"key":"B213","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0923-1811(00)00149-3","article-title":"Clinical significance of enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid","volume":"26","author":"Amo","year":"2001","journal-title":"J Dermatol Sci"},{"key":"B214","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/sj.jid.5700681","article-title":"IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice","volume":"127","author":"Zone","year":"2007","journal-title":"J Invest Dermatol"},{"key":"B215","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/bjd.12300","article-title":"Low sensitivity of type VII collagen enzyme-linked immunosorbent assay in epidermolysis bullosa acquisita: serration pattern analysis on skin biopsy is required for diagnosis","volume":"169","author":"Terra","year":"2013","journal-title":"Br J Dermatol"},{"key":"B216","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/exd.13459","article-title":"Biomarkers related to bullous pemphigoid activity and outcome","volume":"26","author":"Giusti","year":"2017","journal-title":"Exp Dermatol"},{"key":"B217","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fmed.2018.00139","article-title":"High index values of enzyme-linked immunosorbent assay for BP180 at baseline predict relapse in patients with bullous pemphigoid","volume":"5","author":"Koga","year":"2018","journal-title":"Front Med"},{"key":"B218","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1001\/archdermatol.2009.53","article-title":"Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study","volume":"145","author":"Bernard","year":"2009","journal-title":"Arch Dermatol"},{"key":"B219","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/jamadermatol.2013.5757","article-title":"Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study","volume":"150","author":"Fichel","year":"2014","journal-title":"JAMA Dermatol"},{"key":"B220","doi-asserted-by":"crossref","first-page":"119","DOI":"10.47102\/annals-acadmedsg.V44N4p119","article-title":"Anti-BP180 NC16A IgG titres as an indicator of disease activity and outcome in asian patients with bullous pemphigoid","volume":"44","author":"Cai","year":"2015","journal-title":"Ann Acad Med Singapore"},{"key":"B221","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3389\/fimmu.2018.00570","article-title":"Anti-type VII collagen antibodies are identified in a subpopulation of bullous pemphigoid patients with relapse","volume":"9","author":"Giusti","year":"2018","journal-title":"Front Immunol"},{"key":"B222","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/srep18001","article-title":"Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome","volume":"5","author":"Plee","year":"2015","journal-title":"Sci Rep"},{"key":"B223","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jaci.2016.08.012","article-title":"Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes","volume":"139","author":"Riani","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B224","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1038\/s41598-017-04687-5","article-title":"Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome","volume":"7","author":"Giusti","year":"2017","journal-title":"Sci Rep"},{"key":"B225","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/exd.13444","article-title":"Variation of the epidermal expression of glucocorticoid receptor-beta as potential predictive marker of bullous pemphigoid outcome","volume":"26","author":"Brulefert","year":"2017","journal-title":"Exp Dermatol"},{"key":"B226","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.jaad.2015.10.051","article-title":"Immunologic prediction of relapse in patients with pemphigus vulgaris (PV) in clinical remission","volume":"74","author":"Daneshpazhooh","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B227","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jaad.2017.07.012","article-title":"Developing biomarkers for predicting clinical relapse in pemphigus patients treated with rituximab","volume":"77","author":"Albers","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B228","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00105-019-4391-y","article-title":"[Autoimmune bullous dermatoses : update on treatments and rare forms]","volume":"70","author":"Schmidt","year":"2019","journal-title":"Hautarzt"},{"key":"B229","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3389\/fimmu.2019.00978","article-title":"Current clinical trials in pemphigus and pemphigoid","volume":"10","author":"Izumi","year":"2019","journal-title":"Front Immunol"},{"key":"B230","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/bjd.15114","article-title":"Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid","volume":"177","author":"Hashimoto","year":"2017","journal-title":"Br J Dermatol"},{"key":"B231","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1586\/1744666X.2016.1123092","article-title":"IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases","volume":"12","author":"van Beek","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"B232","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jaci.2008.11.035","article-title":"Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab","volume":"123","author":"Fairley","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B233","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1067\/mjd.2000.103986","article-title":"IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity","volume":"42","author":"Dopp","year":"2000","journal-title":"J Am Acad Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01974\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T07:45:02Z","timestamp":1695109502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01974\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,20]]},"references-count":233,"alternative-id":["10.3389\/fimmu.2019.01974"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01974","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,20]]},"article-number":"1974"}}